Studying of psychical adaptation features and peroxide lipids oxidation in patients suffering from community-acquired pneumonia in Belarus prisons

D. V. Lapitski (Minsk, Belarus)

Source: Annual Congress 2006 - Diagnosis and treatment in community-acquired pneumonia
Session: Diagnosis and treatment in community-acquired pneumonia
Session type: Electronic Poster Discussion
Number: 2233
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. V. Lapitski (Minsk, Belarus). Studying of psychical adaptation features and peroxide lipids oxidation in patients suffering from community-acquired pneumonia in Belarus prisons. Eur Respir J 2006; 28: Suppl. 50, 2233

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Features of peroxide lipids oxidation in patients with community-acquired pneumonia in Belarus prisons
Source: Eur Respir J 2006; 28: Suppl. 50, 1s
Year: 2006

Structure of the basic pathogens of bacterial bronchitis and pneumonia in hospitalized patients in Belarus
Source: Eur Respir J 2006; 28: Suppl. 50, 4s
Year: 2006

Differential clinical and etiological features in young and elderly patients hospitalized due to community-acquired pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 354s
Year: 2002

Signs and symptoms indicative of community-acquired pneumonia in young children in Brazil
Source: Eur Respir J 2005; 26: Suppl. 49, 166s
Year: 2005

Peculiarities of community-acquired pneumonia in tobacco-smoking patients
Source: Annual Congress 2009 - Tobacco: from smoke to disease
Year: 2009

Etiology and antibiotic resistance patterns in adults with severe community-acquired pneumonia in Russia
Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Year: 2019

Late Breaking Abstract - Biomarkers for iron metabolism among patients hospitalized with community-acquired pneumonia caused by SARS-CoV-2, bacteria, and influenza
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021


Risk factors for immunosuppression in hospitalized patients coming from the community with pneumonia: a worldwide perspective
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018




Community acquired pneumonia in elderly people: aetiology and antimicrobial drug susceptibility
Source: Eur Respir J 2004; 24: Suppl. 48, 414s
Year: 2004

Incidence of pneumococcal pneumonia in Catalonian elderly people living in the community
Source: Eur Respir J 2006; 28: Suppl. 50, 741s
Year: 2006

Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted into secondary hospitals
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012


Prevalence of nosocomial pneumonia in patients of the general surgical departments
Source: Eur Respir J 2003; 22: Suppl. 45, 335s
Year: 2003

Epidemiology of community-acquired pneumonia in general and high-risk elderly population
Source: Eur Respir J 2006; 28: Suppl. 50, 456s
Year: 2006

Evaluation of thiol/disulfide redox status in community-acquired pneumonia
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017


Etiology and clinical outcome of community-acquired pneumonias in hospitalized children
Source: Eur Respir J 2007; 30: Suppl. 51, 398s
Year: 2007

Particularities of community-acquired pneumonia in the elderly
Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections
Year: 2007


TB outbreak in a hospital for chronic psychiatric diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 166s
Year: 2002

The aetiology of community-acquired pneumonia among servicemen during armed conflict in the Northern Caucasus and the efficiency of pneumococcus vaccine for its prevention
Source: Eur Respir J 2001; 18: Suppl. 33, 463s
Year: 2001

The general evaluation of elderly patients with community acquired pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 412s
Year: 2004

Criteria for clinical stability in hospitalised patients with community-acquired pneumonia
Source: Eur Respir J 2013; 42: 742-749
Year: 2013